Tumor Angiogenesis
Downloads
Tumor angiogenesis, a process in which blood vessels penetrate and grow in a tumor environment, is needed for oxygen and nutrient supply and plays an important role in the survival of solid neoplasms. Angiogenesis does not only have a role in tumor development and metastasis, but also acts as marker of cancer itself (hallmark of cancer). Several mechanisms of angiogenesis include vasculogenesis, sprouting angiogenesis, intussusception microgrowth, and vasculogenic mimicry. Knowing these different mechanisms will be helpful in choosing the best agents or drugs for cancer therapy. The first anti-angiogenic drug used was bevacizumab, a monoclonal antibody, directed against VEGF. Bevacizumab has significant clinical benefits in patients with advanced NSCLC.
De La Puente P, Muz B, Azab F and Azab AK. Cell Trafficking of Endothelial Progenitor Cells in Tumor Progression. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research. 2013; 19: 3360-8.
Darland C and D'Amore PA. Endothelial Cells and Pericytes in Tumor Vasculature. In: Voest EE and D'Amore PA, (Eds.). Tumor Angiogenesis and Microcirculation. Switzerland: Marcell Dekker, Inc., 2001, P. 1-2.
Folkman J. Tumor Angiogenesis: From Bench to Bedside. In: Marmé D and Fusenig N, (Eds.). Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy. Berlin, Heidelberg: Springer Berlin Heidelberg, 2008, P. 3-28.
Eichmann A, Bouvrée K and Pardanaud L. Vasculogenesis and Angiogenesis In Development. In: Marmé D and Fusenig N, (Eds.). Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy. Berlin, Heidelberg: Springer Berlin Heidelberg, 2008, P. 31-45.
Kedokteran PNP. Kanker Paru. In: Nasional KPK, (Ed.). Jakarta: Komite Penanggulangan Kanker Nasional, 2017.
Forman D and Ferlay J. The Global and Regional Burden of Cancer. In: Stewart BW, (Ed.). World Cancer Report 2014. Lyon: WHO Press, 2014, P. 16-27.
Society AC. Cancer Facts & Figures 2017. In: Research S, (Ed.). Atlanta: American Cancer Society, 2018.
Hanahan D and Weinberg RA. Hallmarks of Cancer: The Next Generation. Cell. 2011; 144: 646-74.
Hanahan D and Weinberg RA. Oxford Textbook of Oncology. The Hallmarks of Cancerperspectives for Cancer Medicine. Oxford University Press, 2016.
Weis S and Cheresh D. Weis SM, Cheresh Datumor Angiogenesis: Molecular Pathways and Therapeutic Targets. Nat Med 17: 1359-1370. Nature Medicine. 2011; 17: 1359-70.
Shetty P, Shah K and Viswanathan C. Understanding Vascular Biology with the Help of Endothelial Progenitor Cells. Enliven: Journal of Stem Cell Research & Regenerative Medicine. 2015; 02.
Urbich C and Dimmeler S. Endothelial Progenitor Cells: Characterization and Role in Vascular Biology. Circ Res. 2004; 95: 343-53.
Zuazo-Gaztelu I and Casanovas O. Mechanisms of Tumor Angiogenesis. In: Marmé D, (Ed.). Tumor Angiogenesis: A Key Target for Cancer Therapy. Cham: Springer International Publishing, 2019, P. 3-31.
Arriaga Y and Frankel A. Angiogenesis. In: Kerr DJ, Haller DG, Van De Velde CJ and Baumann M, (Eds.). Oxford Textbook of Oncology 3rd Edition. Oxford: Oxford University Press, 2016, P. 50-8.
Jain RK. Molecular Regulation of Vessel Maturation. Nature Medicine. 2003; 9: 685-93.
Geudens I and Gerhardt H. Coordinating Cell Behaviour during Blood Vessel Formation. Development (Cambridge, England). 2011; 138: 4569-83.
Iruela-Arispe ML and Davis GE. Cellular and Molecular Mechanisms of Vascular Lumen Formation.
Developmental Cell. 2009; 16: 222-31.
Burri PH, Hlushchuk R and Djonov V. Intussusceptive Angiogenesis: Its Emergence, Its Characteristics, and Its Significance. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 2004; 231: 474-88.
Jayson G and O'Connor J. Imaging Tumor Angiogenesis. 2019, P. 277-90.
Di Maio M, Novello S, Capelletto E and Scagliotti GV. Inhibition of Tumor Angiogenesis in the Treatment of Lung Cancer. In: Marmé D, (Ed.). Tumor Angiogenesis: A Key Target for Cancer Therapy. Cham: Springer International Publishing, 2017, P. 1-15.
Copyright (c) 2018 Farah Fatmawati, Whendy Wijaksono
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.
JR (